Measles: all 134 studies
Page 2 of 2. Open to participants first (17), then studies with results posted, then the rest; newest registration first within each.
- Making Decisions About the Measles-Mumps-Rubella VaccineCompletedNCT01369394Not applicable
- Measles, Mumps, and Rubella (MMR) Immunity in College StudentsCompletedNCT00962819
- Seroimmunity 2007 and Sub Study of the Swedish Population Regarding Vaccine Preventable DiseaseStatus unknownNCT00932269
- Study to Evaluate Safety, Dose Response and Immunogenicity of the Measles Vaccine MVA mBN85B in Healthy Children Aged 6 Months to 6 YearsCompletedNCT00891007Phase 2
- Measles Vaccine in Patients With Measles Virus-Positive, Advanced Non-Small Cell Lung CancerStatus unknownNCT00828022Phase 1/2
- The Influence of Probiotics on the Immunologic Response to Vaccinations in InfantsStatus unknownNCT00645996Not applicable
- Study of Post-Training Supports for Health Workers in BeninCompletedNCT00510679Not applicable
- Safety Study of a Refrigerator-stable Formulation of VARIVAX®CompletedNCT00432731Phase 4
- Immunogenicity and Safety of Concomitant Administration of MMR™ rHA and VARIVAX® by Intramuscular Versus Subcutaneous Route (V205C-011)CompletedNCT00432523Phase 3
- Long-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined VaccineCompletedNCT00406211Phase 3
- Assess GSK Biologicals' MMR Vaccine (Priorix) When Given to Healthy Children at the Age of 12 to 18 Months in Singapore.CompletedNCT00388440Phase 4
- Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™CompletedNCT00353288Phase 2
- Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™CompletedNCT00352898Phase 2
- Immunogenicity/Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA): Using Two Different Administration RoutesCompletedNCT00351923Phase 3
- Immunogenicity and Safety of Hepatitis A Vaccine Given at the Same Time of Measles, Mumps, Rubella Combined VaccineCompletedNCT00313950Phase 4
- Immune Responses to Two Dose Varivax +/- MMR-IITerminatedNCT00258726Phase 1/2
- Impact of HIV on Measles and Measles ImmunisationCompletedNCT00247091
- Ontogeny of Measles Immunity in InfantsCompletedNCT00240916
- Non-Specific Effects of Standard Titre Measles VaccinationCompletedNCT00168662Phase 4
- Long-term Follow-up of Measles AntibodiesCompletedNCT00168571Phase 4
- Early Two-dose Measles Vaccination TrialCompletedNCT00168558Phase 4
- Immunology of Non-specific Effects of VaccineCompletedNCT00168545Phase 4
- Prophylactic Antibiotics in MeaslesCompletedNCT00168532Phase 3
- MMR and Varicella Vaccine in Premature InfantsCompletedNCT00156559
- Responses of Premature Infants to Measles-Mumps-Rubella (MMR) and Varicella VaccinesTerminatedNCT00138255
- Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox DiseasesCompletedNCT00127023Phase 3
- Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox DiseasesCompletedNCT00127010Phase 3
- Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox DiseasesCompletedNCT00126997Phase 4
- A Measles, Mumps, and Rubella Investigational Vaccine Trial (V205C-010)(COMPLETED)CompletedNCT00109278Phase 2
- Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016)CompletedNCT00092430Phase 3
- Safety, Tolerability, and Immunogenicity of an Investigational Vaccine With Recombinant Human Albumin (rHA) in Children 12 to 18 Months of Age (V205C-009)(COMPLETED)CompletedNCT00092404Phase 2
- A Study of An Approved Vaccine at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age (V205C-007)(COMPLETED)CompletedNCT00092391Phase 3
- Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV DrugsCompletedNCT00013871Not applicable
- A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials GroupCompletedNCT00000815Phase 2